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Simple, sensitive, and economical simultaneous volumetric and HPLC methods for the determination of pridinol mesylate in raw
material have been developed. The volumetric method is based on the reaction of pridinol with sodium lauryl sulphate in diluted
sulphuric acid. Dimethyl yellow was used as indicator to detect the end point of the titration in aqueous/organic layer. The HPLC
method for the determination of pridinolmesylate employs a reverse phase C18 column at ambient temperature with amobile phase
consisting of acetonitrile: 0.05M potassium dihydrogen phosphate, pH adjusted to 5.0 (1 : 2, v/v). The flow rate was 0.8mL/min.
Quantitation was achieved with UV detection at 258 nm based on peak area. Bothmethods were found to be suitable for the quality
control of pridinol mesylate in raw material.
1. Introduction
Pridinol mesylate (Figure 1) is a CNS acting muscle relaxant
used for treating muscle spasms [1]. It is administered orally
and by intramuscular injection, and it has also been applied
in topical preparations [1]. However, pridinol mesylate is
most frequently found in associations with nonsteroidal
anti-inflammatory agents, including sodium or potassium
diclofenac and meloxicam. The usual dosis is 4.0mg.
A literature survey revealed some high-performance
liquid chromatographic methods for the quantitation of
pridinol mesylate in the presence of its relevant degradation
impurities [2] or in the presence of its process-related
impurities [3] in bulk drug. Both methods use a C18 column
and mixtures of potassium phosphate buffer, methanol and
2-propanol as the mobile phase [2, 3]. Another analytical
technique for pridinol mesylate described in the literature is
based on the liquid chromatographic determination of this
drug in pharmaceutical formulations with meloxicam [4].
The present paper describes a simple, rapid, precise, accu-
rate, and economic volumetric method for the quantitation
of pridinol mesylate in raw material. Results of precision and
accuracy of the volumetric method were comparable with
an isocratic reversed-phase HPLC method developed for the
determination of pridinol mesylate in raw material.
The method was validated by following the analyti-
cal performance parameters suggested by the International
Conference on Harmonization (ICH) [5]. Previously we
have described an HPLC method for the quantitation of
Meprednisona in tablets, and we use the same lineaments [6].
2. Materials and Methods
Pridinol mesylate (99.6%) was obtained from Aldrich-Sigma
(Saint Louis, MO, USA). Acetonitrile used was HPLC Grade,
J. T. Baker, Estado de Mexico, Mexico. Potassium dihydrogen
phosphate was from AR Grade, J. T. Baker, Estado de
Mexico, Mexico; Sulphuric acid, AR Grade (Merck, Darm-
stadt, Germany); Dichloromethane, AR Grade (Mallinck-
rodt, New York, USA); Dimethyl yellow, AR Grade (Aldrich-
Sigma, Saint Louis, MO, USA); and Sodium Lauryl Sul-
phate (Flamaquı´mica, Argentina). Papaverine hydrochloride
(98.9%) was obtained fromDrogueria Saporiti, Buenos Aires,
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Figure 1: Pridinol mesylate.
Table 1: Volumetric linearity.
% (w/v) of nominal
value Weighed (𝜇g) Volume consumed
25 0.0218 5.7
50 0.0370 9.6
75 0.0545 14.2
100 0.0710 18.5
125 0.0869 22.7
Slopea 0.2605061 ± 1.4117187
Interceptb 0.0254146 ± 83.5200138
aConfidence limits of the slope (𝑃 = 0.05).
bConfidence limits of the intercept (𝑃 = 0.05).
Argentina. Distilled water was passed through a 0.45𝜇m
membrane filter.
2.1. Volumetry
2.1.1. Reagent and Materials. 10% (w/v) sulphuric acid
was prepared by appropriate dilution of concentrated Sul-
phuric acid. Dimethyl yellow 1.0% (w/v) was prepared in
dichloromethane. Sodium lauryl sulphate 0.01N was pre-
pared by diluting 2.88 g in 1000mL of distilled water.
2.1.2. Standardization. Sodium lauryl sulphate solution
0.01N was standardized with papaverine hydrochloride.
50mg of papaverine hydrochloride accurately weighed was
placed in a 100mL conical flask and dissolved in 20mL of
distilled water and 5mL of 10% (w/v) sulphuric acid. 20mL of
dichloromethane and 3 drops of indicator were then added.
After being vigorously shaken, the solution was titrated with
0.01N sodium lauryl sulphate until the organic layer changed
from yellow to red-orange at the end of titration.
2.2. General Procedure. Each amount of pridinol mesylate
was accurately weighed, transferred to a 100mL conical flask,
and dissolved in 20mL of distilled water and 5mL of 10%
(w/v) sulphuric acid. 20mL of dichloromethane and 3 drops
of indicator were added afterwards. After vigorous shaking,
the solution was titrated with 0.01N sodium lauryl sulphate
previously standardized. After each amount of titrant was
added, the flask was shaken vigorously until the organic layer
changed from yellow to red-orange at the end of titration.
2.3. Method Validation
2.3.1. Linearity. Linearity solutions were prepared at five
concentrations levels from 25% (w/v) to 125% (w/v) of analyte
concentration.
2.3.2. Precision. Precision of the method was checked by
carrying out six independent assays of pridinol mesylate raw
material. Intermediate precision was performed by analyzing
the samples by two different analysts on different days.
2.3.3. Accuracy. The accuracy was evaluated by the recovery
studies at concentration levels of 75, 100, and 125% (w/v) (3
samples each). The amount of pridinol mesylate recovered in
relation to the added amount was calculated.
2.4. HPLC Method
2.4.1. Equipment. The HPLC system consisted of a dual pis-
ton reciprocating Spectra Physics pump (Irvine, CA, United
States, Model ISO Chrom. LC pump), a UV-Vis Hewlett
Packard detector (Model 1050), a Hewlett Packard integrator
(Loveland, CO, United States, Series 3395), and a Rheodyne
injector (Model 7125).
2.4.2. Chromatographic Conditions. The analytical column
was a reversed phase C18 column (Keystone ODS/A (250 ×
3mm, 5𝜇m) Keystone Scientific Inc. The separation was
carried out under isocratic elution with acetonitrile: 0.05M
potassium dihydrogen phosphate, pH adjusted to 5.0 (1 : 2,
v/v). The flow rate was 0.8mL/min. The wavelength was
monitored at 258 nm, and the injection volume was 20𝜇L.
TheHPLCwas operated at ambient temperature. Under these
conditions, the retention time (𝑡
𝑅
) of pridinol mesylate was
approximately 4.8min.
2.4.3. Standard Solutions. A standard stock solution of pridi-
nol mesylate was prepared at a concentration of 0.88mg/mL
in mobile phase and filtered through a 0.2𝜇m nylon
membrane (25mm disposable filter; Cat. N∘ Y02025WPH
𝜇icroclar, Buenos Aires, Argentina). The solution remained
stable for 3 days stored at 2–8∘C, in the dark.
2.4.4. Sample Preparation. Approximately 25mg of pridinol
mesylate raw material was accurately weighted and diluted
in mobile phase in order to obtain a concentration of
0.88mg/mL.The sample was filtered through a 0.2𝜇m nylon
membrane (25mm disposable filter; Cat. N∘ Y02025WPH
𝜇icroclar, Buenos Aires, Argentina).
2.5. Method Validation
2.5.1. System Suitability. Relative standard deviations (RSD)
values of the peak area, tailing factor, retention time, capacity,
and theoretical plates were the chromatographic parameters
selected for the system suitability test [7].
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Table 2: Volumetric precision.
Sample no. of analyst 1 Weighed (mg) Percentage Sample no. of analyst 2 Weighed (mg) Percentage
1 71.0 100.0 1 69.8 100.0
2 70.9 100.1 2 70.2 100.0
3 72.4 100.1 3 71.1 99.8
4 71.6 100.2 4 71.0 100.0
5 72.8 100.1 5 69.9 99.9
6 71.1 100.3 6 71.6 100.2
Mean 71.6 100.1 70.6 100.0
RSD 1.1 0.1 1.0 0.1
Table 3: Volumetric accuracy.
% of nominal value Added amount (mg) Found amount (mg) Recovery (%) Average recovery (𝑛 = 3) RSD (%)
75
54.1 54.0 100.0
100.2 0.354.0 54.0 100.0
55.3 55.6 100.5
100
71.0 70.9 99.8
99.9 0.171.7 71.6 99.9
70.2 70.1 99.9
125
87.0 87.0 100.0
99.9 0.186.0 85.8 99.8
87.8 87.7 99.9
Mean (𝑛 = 9) 100.0 0.2
Table 4: System suitability.
Parameter Minimumvalue
Maximum
value Average RSD (%)
Retention time 4.869 4.880 4.871 0.29
Area 4674893 4745226 4710059.5 1.05
Capacity 2.13 2.14 2.135 0.33
Tailing factor 1.0 1.04 1.02 2.77
Theoretical plates 8636.6 9502.35 9069.47 6.77
Table 5: Selectivity.
Condition Time(h)
% of Pridinol
Mesilate
RRT of degradation
products
Acid (6NHCl, reflux) 0.5 9.8 0.29, 0.33, 0.4, 0.49,1.24, 1.88, 2.26
Base (5NNaOH, reflux) 0.5 11.5 0.23, 0.33
Hydrogen peroxide 100
vol (reflux)
0.5 68.2 0.33, 1.16, 1.6
Dry heat, 50∘C (solid) 1.5 99.5 0.35
Daylight exposure 96 100.4 Non detected
RRT: relative retention time.
2.5.2. Specificity. Forced degradation studies were performed
to evaluate the specificity of the method. Degraded samples
were prepared by refluxing 1.76mg/mL pridinol mesylate
working standardwith acid (6Nhydrochloric acid), base (5N
NaOH), water, and 30% hydrogen peroxide and refluxing
for at least 30min. The drug was subjected to thermal
Table 6: HPLC linearity.
% of nominal
value
Injected
(𝜇g)
Average peak area
response RSD
2.5 0.44 124724.7 0.6
5 0.88 240208.5 1.3
10 1.76 465203.0 0.2
25 4.40 1253760.0 0.3
50 8.80 2375012.0 1.4
75 12.36 3192030.0 1.2
100 17.60 4618572.7 0.1
125 21.60 5467281.0 0.5
150 24.70 6203272.0 0.8
Slopea 251840.13 ± 812125.44
Interceptb 70530.92 ± 11502975.25
aConfidence limits of the slope (𝑃 = 0.05).
bConfidence limits of the intercept (𝑃 = 0.05).
degradation in the solid state in an open container in an
oven at 50∘C for 1.5 h and to photochemical degradation
(a solution was transferred to a container and exposed to
daylight for 96 h). After each degradation treatment, samples
were allowed to cool at room temperature and diluted, to
the same concentration as that of the standard solution, after
being neutralized. After degradation, samples were analyzed
using the methodology and the chromatographic conditions
described.
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Table 7: HPLC precision and accuracy.
% of nominal value Added amount(mg) Found amount (mg) Recovery (%) Average recovery (𝑛 = 3) RSD (%)
80
33.0 32.8 99.3
99.4 0.432.0 31.6 99.0
32.6 32.1 99.8
100
21.0 20.9 99.5
100.3 0.720.7 20.9 100.9
21.3 21.4 100.5
120
25.2 25.3 100.4
100.8 0.424.7 25.0 101.2
25.0 25.2 100.8
Mean (𝑛 = 9) 100.2 1.0
Table 8: Robustness.
Mobile Phase RT pridinol mesylate. RSD Tailing 𝑁 % RSD
Acetonitrile : buffer (0.8 : 2) 8.747 0.11 1.02 30276 101.9 0.21
Acetonitrile : buffer (2 : 2) 2.296 0.03 1.07 8438.2 99.7 1.70
Acetonitrile : buffer (2 : 1) pH 5 5.790 0.23 1.03 13370.3 101.7 0.48
Acetonitrile : buffer (2 : 1) pH 6.4 6.588 0.24 1.00 69484.9 99.3 0.44
2.5.3. Linearity. Linearity solutions were prepared at nine
concentrations levels from 2.5% (w/v) to 150% (w/v) of
analyte concentration.
2.5.4. Precision and Accuracy. Both reproducibility and accu-
racy studies were evaluated by carrying out nine independent
assays at concentration levels of 80, 100, and 120% (w/v) (3
samples each). Raw material was used in these assays. The
amount of pridinol mesylate recovered was calculated.
2.5.5. Robustness. Robustness was performed by deliber-
ately changing the chromatographic conditions. The relative
organic portion ratio of the eluent was varied by 0.8 to 2.0,
while pH was varied by ±1.4 units. RSD, retention time,
tailing, and theoretical plates were evaluated.
3. Results and Discussion
In acidic solutions, the nitrogenous drugs are present in their
positively charged form.The improved dissolution of pridinol
mesylate at lower pH is probably due to the protonation of
the piperidinic nitrogen (pKa = 9.7) [8]. The anionic titrant
interacts with the positively charged pridinol to form ion-pair
or ion-associate complexes which are extractable into organic
solvents. The aqueous to organic solvent ratio 1 : 1 was the
more suitable for the extraction of ion pair or ion-associate
complexes. At the end point, the titrant interacts with the
basic dye to form ion-pair or ion-associate complexes which
changes the color of the organic layer from yellow to red-
orange.
The proposed procedure has been satisfactorily applied to
the quantitation of pridinol mesylate in raw material.
The linearity of the volumetric method was determined
by analysis of three replicates of five concentrations of stan-
dard solutions from 25% (w/v) to 125% (w/v).The calibration
curve showed good linearity over the concentration range.
The correlation coefficient (“𝑟”) value was 0.9998. Typically,
the regression equation for the calibration curve was found
to be 𝑦 = 0.2605061𝑥 + 0.0254146. The linearity of the
calibration graphs was validated by the high value of the
correlation coefficient and the intercept value that was not
statistically (𝑃 = 0.05) different from zero (Table 1).
The precision of an analytical procedure expresses the
closeness of the agreement between a series of measurements
obtained from multiple sampling of the same homogeneous
sample under the prescribed conditions.
The intraday precision of the volumetricmethodwas per-
formed by assaying the samples on two different days by two
different analysts. The results were given both individually
and as the average. For each precision assay the results were
as follows: mean values 100.1 and 100.0% and RSD 1.1% and
1.0%. 𝑇 test comparing two samples with 95% confidence for
10 degrees of freedom disclosed that both results were not
significantly different inter se (𝑡
𝑛−2,𝛼:0.05
) = 2.23 (Table 2).
Method accuracy of the volumetric method was also
demonstrated by plotting the amount of pridinol mesylate
measured against the amount present in the samples, both
expressed in mg. Linear regression analysis rendered slopes
not significantly different from 1 (𝑡-test 𝑃 = 0.05), intercepts
not significantly different from zero (𝑡-test 𝑃 = 0.05), and
𝑟 = 0.9999; the RSD was 0.2. The experimental 𝑡 of the
recovery percentage whose value was 0.750 was also studied,
being it far below the 2.306 established in the tabulated t (95%
level of probability, 8 d.f.) (Table 3).
The described reverse-phase liquid chromatography
method was developed to provide a rapid quality control
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determination of pridinol mesylate in raw material. Valida-
tion of the method was performed according to ICH. This
method uses a simple mobile phase. All samples were ana-
lyzed using the assay chromatographic conditions described.
The analytical column was equilibrated with the eluting
solvent system used. After an acceptably stable baseline was
achieved, the standards and then the samples were analyzed.
System suitability results were calculated according to
the USP 32 ⟨621⟩ from typical chromatograms. Instrument
precision was determined by six successive injections of the
standard preparation provided a relative standard deviation
(RSD) below 1.5%. Peak asymmetry or tailing factor, 𝑇, was
calculated as 𝑇 = 𝑊
0.05
/2𝑓, where𝑊
0.05
is the distance from
the leading edge to the tailing edge of the peak, measured
at 5% of the peak height from the baseline, and 𝑓 is the
distance from the peak maximum to the leading edge of the
peak. The tailing factor did not exceed 1.5. The RSD of peak
area response and retention time showed the satisfactory
repeatability of the system (<1.5%) (Table 4).
Stability of the standard solution and sample preparation
was studied by injecting the prepared solution at periodic
intervals into the chromatographic system up to about 72
hours stored at 2–8∘C.
Degradation was indicated in the stressed sample by
a decrease in the expected concentration of the drug and
increased levels of degradation products. Pridinol mesylate
was degraded to different products under acid, base, and
oxidation (Table 5). In addition, there was no interference
regarding the retention time of pridinol mesylate and its
degradation products.
The linearity of the HPLC method was determined by
analysis of three replicates of nine concentrations of standard
solutions (ranging from 0.44 to 24.70𝜇g injected). The cali-
bration curve showed good linearity over the concentration
range. The correlation coefficient (“𝑟”) value was 0.9995.
Typically, the regression equation for the calibration curve
was found to be 𝑦 = 251840𝑥 + 70531. The linearity of
the calibration graphs was validated by the high value of the
correlation coefficient and the intercept value that was not
statistically (𝑃 = 0.05) different from zero (Table 6).
The system precision is a measure of the method vari-
ability that can be expected for a given analyst performing
the analysis and was determined by performing six replicate
analyses of the same working solution. The relative standard
deviation (RSD) obtained was 0.4.
The precision is usually expressed as the RSD of a series
of measurements. The reproducibility and accuracy studies
were evaluated by recovery studies with 9 samples of one
commercial formulation studied (𝑛 = 3 for 80%, 100%, and
120%) which indicated that the mean recovery was 100.2%
and the RSD was 1.0.
Method accuracy was also demonstrated by plotting
the amount of pridinol mesylate found against the amount
present in the sample, both expressed in mg. Linear regres-
sion analysis rendered slopes not significantly different from
1 (𝑡-test 𝑃 = 0.05), intercepts not significantly different from
zero (𝑡-test 𝑃 = 0.05), and 𝑟 = 0.9995. The experimental 𝑡 of
the recovery percentage was also studied, showing a value of
0.750, far below the 2.306 established in the tabulated t (95%
level of probability, 8 d.f.) (Table 7).
The robustness of an analytical procedure is a measure
of its capacity to remain unaffected by small, but deliberate
variations in method parameters and provides an indication
of its reliability during normal usage.
Robustness of the method was investigated under a
variety of conditions including changes of pH and percentage
of acetonitrile in the mobile phase.
The effect on retention time, theoretical plates and tailing
factor can be seen in Table 8. An increase in acetonitrile pro-
portion reduces both retention time and theoretical plates.
It was found that retention time of pridinol mesylate was
significantly affected by pH changes.
The volumetric method proposed is simple, rapid, and
inexpensive and can therefore be applied to the determina-
tion of pridinol mesylate in raw material. Method validation
yielded good results and included precision and accuracy.
A straightforward, specific, linear, precise, and accurate
RP-HPLC method has been developed and validated for
quantitative determination of pridinol mesylate in raw mate-
rial.Themethod is very simple and specific, as the peak is well
separated from its impurities with total runtime of 15min,
which makes it especially suitable for routine quality control
analysis work.
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